CITIUS® is 5% Ceftiofur HCL, Fast-Acting, Ready-To-Use Suspension Injection, specifically for treating acute respiratory diseases.
DESCRIPTION
Citius® is an injectable 5% ceftiofur hydrochloride RTU preparation with unique pharmacodynamics that concentrates the active ingredient in the injection site.
Citius® is characterized by better homogeneity, lesser viscosity, high bioavailability, broad-spectrum bactericidal activity with low MICs against pathogens, a fast bacterial reaction time of less than 1 hour, flexibility in the route of administration (intramuscular and subcutaneous) and easy syringeability.
WHAT IS CITIUS?
Citius® is an injectable suspension containing Ceftiofur. Ceftiofur is an antibiotic of the Cephalosporin group, with a broad antibacterial spectrum including Gram (-) and Gram (+) bacteria, including Beta lactamase - producing bacteria.
Citius® 5% contains micromolecular Ceftiofur and excipients that allow this antibiotic to disperse very quickly in the body. Serum and tissue concentrations reach therapeutic concentrations in less than 15 minutes, allowing this antibiotic to take effect very quickly after injection.
INGREDIENT
Each 1 ml contains:
-Ceftiofur ....................... 50mg
-Sufficient excipients ........1ml
INDICATIONS
WHY CHOOSE CITIUS®?
DOSAGE AND INSTRUCTIONS FOR USE
WHY CHOSE CITIUS®?
STORAGE
Store the medicine in a cool, dry place at a temperature below 30℃ away from direct light.
SPECIFICATIONS
100ml
ACTIVE INGREDIENTS
Ceftiofur
DOSAGE
50 mg/mL
PHARMACEUTICAL FORM
Suspension for Injection (IN/SC)
UNITS IN PACKAGE
Type I Amber GLass Vial with Blue Flip-off x 100ml
SUM-UP
In cattle for the treatment of respiratory infections caused by: Manheimmia haemolytica, Pasteurella multocida, Histophlus somni. In Pigs, for the treatment of respiratory infections associated with: Actinobacillus pleuropneumoniae, Pasteurella multocida, Salmonella cholerasuis, Streptooococcus suis type 2.
Bactericidal effect that acts by inhibiting cell wall synthesis. Indicated for the treatment of pododermatits, metritis , respiratory diseases, disorders caused by Streptococcus suis type 2, as an auxiliary in the treatment of neonatal diarrheal syndrome.
ADVANTAGES
DOSAGE AND INSTRUCTIONS FOR USE
a) Dose
b) Route of Administration
WITHDRAWAL TIME
PRECAUTIONS
WARNINGS
The use of the product can generate positive results for Ceftiofur residues when tests are used whose sensitivity allows detecting in the milk of treated animals, levels lower than those established by the Ministry of Health and Social Protection through resolution number 1382 of 2013 (100 μg/L or ppm).